Currently out of the existing stock ratings of Anthony Vendetti, 108 are a BUY (85.04%), 15 are a HOLD (11.81%), 4 are a SELL (3.15%).

Anthony Vendetti

Work Performance Price Targets & Ratings Chart

Analyst Anthony Vendetti, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 35.5% that have a potential upside of 38.85% achieved within 164 days.

Anthony Vendetti’s has documented 232 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on DRMA, Dermata Therapeutics at 21-May-2025.

Wall Street Analyst Anthony Vendetti

Analyst best performing recommendations are on BIOL (BIOLASE).
The best stock recommendation documented was for DRMA (DERMATA THERAPEUTICS) at 5/21/2025. The price target of $3 was fulfilled within 72 days with a profit of $2.23 (289.61%) receiving and performance score of 40.22.

Average potential price target upside

of $20.45 (50.51%) on FIZZ (NATIONAL BEVERAGE CORP).
of $16.29 (57.07%) on NUTX (NUTEX HEALTH).
of $12.54 (57.08%) on HAIN (THE HAIN CELESTIAL GROUP).

AEMD Aethlon Medical APDN Applied DNA Sciences CELH Celsius Holdings FIZZ National Beverage Corp HAIN The Hain Celestial Group MLSS Milestone Scientific PAVM PAVmed RMED RA Medical Systems SIEN Sientra SOLY Soliton SRTS Sensus Healthcare YTEN Yield10 Bioscience ZSAN Zosano Pharma Corp BIOL BIOLASE MDRX Allscripts Healthcare Solutions RSLS ReShape Lifesciences PLSE Pulse Biosciences AGFY Agrify Corp DRMA Dermata Therapeutics UGRO Urban-Gro JYNT The Joint Corp CUTR Cutera REED Reed's VERO Venus Concept DYNT Dynatronics HSDT Helius Medical Technologies ACON Aclarion EDBL Edible Garden AG GHSI Guardion Health Sciences NUTX Nutex Health TNON Tenon Medical

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Vernon Bernardino (HC WAINWRIGHT)